Advanced search    

Search: authors:"Diego Centonze"

26 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

Achieving good adherence to self-injected treatments for multiple sclerosis can be difficult. Injection devices may help to overcome some of the injection-related barriers to adherence that can be experienced by patients. We sought to assess short-term adherence to, and tolerability of, interferon (IFN) β-1a administered via electronic autoinjection device in patients with...

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

Ciro Florio Vincenzo Brescia-Morra Salvatore Cottone Paolo Bellantonio Marinella Clerico Diego Centonze Antonio Uccelli Maria di Ioia 0 Giovanna De Luca 0 Andrea Marcellusi Andrea Paolillo for the BRIDGE

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression

clinical trials for Novartis, Merck Serono, Teva, Bayer Schering, Sanofi-aventis, Biogen Idec, and Roche. Dr. Fabio Buttari received funding for traveling from Teva. Dr. Diego Centonze acted as an Advisory

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis

Background Data from multiple sclerosis (MS) and the MS rodent model, experimental autoimmune encephalomyelitis (EAE), highlighted an inflammation-dependent synaptopathy at the basis of the neurodegenerative damage causing irreversible disability in these disorders. This synaptopathy is characterized by an imbalance between glutamatergic and GABAergic transmission and has been...

Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis

Background Mood disorders, including anxiety and depression, are frequently diagnosed in multiple sclerosis (MS) patients, even independently of the disabling symptoms associated with the disease. Anatomical, biochemical, and pharmacological evidence indicates that type-1 cannabinoid receptor (CB1R) is implicated in the control of emotional behavior and is modulated during...

Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis

Background Absence of clinical and radiological activity in relapsing–remitting multiple sclerosis (RRMS) is perceived as disease remission. We explored the role of persisting inflammation during remission in disease evolution. Methods Cerebrospinal fluid (CSF) levels of interleukin 1β (IL-1β), a major proinflammatory cytokine, were measured in 170 RRMS patients at the time of...

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Centre, University Hospital, Catania, Italy, (2) Girolama Alessandra Marfia and Diego Centonze, Department of Neuroscience, University of Rome Tor Vergata, Rome, Italy, (3) Vincenzo Brescia Morra, MS

Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems

Fino, Gaspare Guglielmi, Massimiliano Mirabella, Viviana Nociti (Fondazione Policlinico Universitario A. Gemelli, Catholic University, Roma). Fabio Buttari, Diego Centonze, Maria Teresa Di Natolo (Tor

Future MS care: a consensus statement of the MS in the 21st Century Steering Group

, Moscow, Russia); Diego Centonze (Neurologist, Rome, Italy); Alasdair Coles (Neurologist, Cambridge, UK); Irina Elovaara (Neurologist, Tampere, Finland); Eva Havrdova (Neurologist, Prague, Czech Republic ... of interest to declare in regards to Merck Serono: Peter Rieckmann has received honoraria and speakers fees; Diego Centonze has a financial arrangement; Alasdair Coles has received honoraria; Irina

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53

Background Understanding how inflammation causes neuronal damage is of paramount importance in multiple sclerosis (MS) and in other neurodegenerative diseases. Here we addressed the role of the apoptotic cascade in the synaptic abnormalities and neuronal loss caused by the proinflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α) in brain tissues, and...

A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission

Teramo, Teramo, ItalyMauro MaccarroneIRCCS Centro per la Neurobiologia Sperimentale C Mondino, Mondino-Tor Vergata-Santa Lucia, Rome, ItalyMauro Maccarrone AuthorsSearch for Diego Centonze in:Nature

Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors

Two isoforms of the dopamine (DA) D2 receptor are generated from the same gene by alternative splicing, D2L and D2S. To identify which isoform is involved in the autoregulation of midbrain DA neuron activity, intracellular electrophysiological recordings were performed from substantia nigra and ventral tegmental area neurons of mice lacking either D2L(D2L−/−) or both D2L and D2S...

Cocaine and Amphetamine Depress Striatal GABAergic Synaptic Transmission through D2 Dopamine Receptors

, FranceEmiliana Borrelli AuthorsSearch for Diego Centonze in:Nature Research journals • PubMed • Google ScholarSearch for Barbara Picconi in:Nature Research journals • PubMed • Google ScholarSearch for Christelle

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)

, Roberto Bruno Bossio, Vincenzo Brescia Morra, Gianfranco Costantino, Paola Cavalla, Diego Centonze, Giancarlo Comi, Salvatore Cottone, Maura Chiara Danni, Ada Francia, Alberto Gajofatto, Claudio Gasperini ... , Gianfranco Costantino, Paola Cavalla, Diego Centonze, Giancarlo Comi, Salvatore Cottone, Maura Chiara Danni, Ada Francia, Alberto Gajofatto, Claudio Gasperini, Mauro Zaffaroni, Loredana Petrucci, Elisabetta

Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study

Background Flu-like syndrome (FLS) is a common adverse event experienced by patients with relapsing-remitting multiple sclerosis (RRMS) treated with interferon beta (IFNβ). FLS can lead to poor treatment adherence and early IFNβ discontinuation. The involvement of interleukin-6 (IL-6) in the occurrence of FLS has been suggested. We hypothesized that cetirizine, a second...

Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis

Centonze 0 Celia Oreja-Guevara, University Hospital La Paz, Spain 0 1 Clinica Neurologica, Dipartimento di Medicina dei Sistemi, Universita` Tor Vergata , Rome , Italy , 2 Centro Europeo per la Ricerca sul

Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis

Background The available clinical outcome measures of disability in multiple sclerosis are not adequately responsive or sensitive. Objective To investigate the feasibility of inertial sensor-based gait analysis in multiple sclerosis. Methods A cross-sectional study of 80 multiple sclerosis patients and 50 healthy controls was performed. Lower-limb kinematics was evaluated by...

Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene

One of the most common adverse event of interferon beta (IFNβ) therapy for multiple sclerosis is flu-like syndrome (FLS), which has been reportedly related to increased levels of cytokines such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Average cytokine levels can be affected by single nucleotide polymorphism in the gene promoter regions. To investigate...

T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients

FoxP3+ Treg cells are believed to play a role in the occurrence of autoimmunity and in the determination of clinical recurrences. Contradictory reports are, however, available describing frequency and function of Treg cells during autoimmune diseases. We examined, by both polychromatic flow cytometry, and real-time RT-PCR, several Treg markers in peripheral blood mononuclear...